Taysha Gene Therapies(TSHA) - 2022 Q2 - Earnings Call Transcript

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q2 2022 Results Conference Call August 11, 2022 8:00 AM ET Company Participants Dr. Kimberly Lee - Chief Corporate Affairs Officer RA Session - President, Founder, and Chief Executive Officer Dr. Suyash Prasad - Chief Medical Officer and Head, R&D Kamran Alam - Chief Financial Officer Dr. Frederick Porter - Chief Technical Officer Conference Call Participants Joon Lee - Jo Securities Gil Blum - Needham & Company Mike Ulz - Morgan Stanley Eun Yang - Jefferies Jack Al ...